| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.94B | +13.6% |
| R&D Expense | $34.0M | -27.7% |
| SG&A Expense | $556.0M | -4.6% |
| Operating Income | $1.34B | -2.0% |
| Interest Expense | $284.0M | +12.3% |
| Pre-tax Income | $1.06B | +352.0% |
| Income Tax | $243.0M | +526.3% |
| Net Income | $727.0M | +229.8% |
| EPS (Basic) | $6.01 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $550.0M | +3.6% |
| Accounts Receivable | $1.84B | -2.4% |
| Inventory | $2.01B | +16.1% |
| Current Assets | $4.66B | +3.6% |
| Total Assets | $14.30B | +3.2% |
| Current Liabilities | $3.93B | -4.9% |
| Long-term Debt | $6.90B | +11.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $803.0M | -11.3% |
| Capital Expenditures | $839.0M | +6.6% |
| Investing Cash Flow | -$642.0M | -142.6% |
| Financing Cash Flow | -$25.0M | +99.2% |
| Free Cash Flow | -$36.0M | -130.5% |
| +239.8% |
| EPS (Diluted) | $5.99 | +239.3% |
| Stockholders' Equity |
| $1.85B |
| -3.3% |